APLS - Apellis Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

APLS is currently covered by 14 analysts with an average price target of $38.17. This is a potential upside of $35.05 (1123.4%) from yesterday's end of day stock price of $3.12.

Apellis Pharmaceuticals's activity chart (see below) currently has 520 price targets and 399 ratings on display. The stock rating distribution of APLS is 34.48% HOLD and 65.52% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 67.94% with an average time for these price targets to be met of 209.2 days.

Highest price target for APLS is $52, Lowest price target is $18, average price target is $38.17.

Most recent stock forecast was given by from CANTOR FITZGERALD on 15-May-2026. First documented stock forecast 04-Dec-2017.

Best performing analysts who are covering APLS - Apellis Pharmaceuticals:

Colleen Kusy Michael Ulz Steven Seedhouse Elemer Piros Annabel Samimy Chris Howerton

Currently out of the existing stock ratings of APLS, 10 are a HOLD (34.48%), 19 are a BUY (65.52%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 15-May-2026

$31

4 months 21 days ago
(15-May-2026)

4/22 (18.18%)

$13.11 (73.28%)

308

Buy Since 20-Jan-2026

$41

$37.23 (987.53%)

$26

5 months 19 days ago
(17-Apr-2026)

15/18 (83.33%)

$0.1 (0.24%)

100

Hold Since 02-Nov-2023

$41

$37.23 (987.53%)

$20

6 months 4 days ago
(02-Apr-2026)

14/19 (73.68%)

$0.59 (1.46%)

147

Buy Since 19-Jul-2022

$41

$37.23 (987.53%)

$48

6 months 5 days ago
(01-Apr-2026)

4/29 (13.79%)

$0.61 (1.51%)

90

Buy Since 19-Jan-2024

$41

$37.23 (987.53%)

$45

6 months 5 days ago
(01-Apr-2026)

16/28 (57.14%)

$0.61 (1.51%)

368

Show more analysts

Please expand the browser size to see the chart

What is APLS (Apellis Pharmaceuticals) average time for price targets to be met?

On average it took 209 days for the stock forecasts to be reached, with an average price target met ratio of 67.94%.

Which analyst most recently updated their price target on APLS (Apellis Pharmaceuticals)?

Which analyst has the most public recommendations on APLS (Apellis Pharmaceuticals)?

has 0 price targets and 0 ratings on APLS

Which analyst is the currently most bullish on APLS (Apellis Pharmaceuticals)?

Akash Tewari with the highest potential upside of $78.23

Which analyst is the currently most reserved on APLS (Apellis Pharmaceuticals)?

Laura Chico with the lowest potential downside of -$23.03
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?